Literature DB >> 18619811

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial.

Jenny L Donovan1, J Athene Lane, Tim J Peters, Lucy Brindle, Elizabeth Salter, David Gillatt, Philip Powell, Prasad Bollina, David E Neal, Freddie C Hamdy.   

Abstract

OBJECTIVE: Multicenter randomized trials are required for pragmatic evaluations of health care interventions, but recruitment is difficult. Systematic reviews failed to identify robust strategies to improve recruitment. We developed and evaluated a complex intervention to increase levels of randomization and informed consent. STUDY DESIGN AND
SETTING: The ProtecT (Prostate testing for cancer and Treatment) trial compares radical surgery, radical conformal radiotherapy, and active monitoring for men aged 50-69 years with localized prostate cancer. The intervention was developed using qualitative research methods (content, thematic and conversation analysis). Rates of randomization and immediate acceptance of allocation were measured every 6 months to evaluate the impact of the intervention.
RESULTS: The complex intervention comprised reviews of centers falling below study targets, training programmes, documents and individually tailored feedback. Over 65% of eligible participants consented to randomization. Trial participants became increasingly well informed as immediate acceptance of allocation rose from 65% to 81% between 2001 and 2005.
CONCLUSION: This complex intervention resulted in high levels of randomization and informed consent in a difficult trial. The generic aspects of the intervention could be applied to other trials to maximize randomization and informed consent, and allow the mounting of trials previously considered too difficult.

Entities:  

Mesh:

Year:  2008        PMID: 18619811     DOI: 10.1016/j.jclinepi.2008.02.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  75 in total

Review 1.  Active surveillance for low-risk prostate cancer: an update.

Authors:  Nathan Lawrentschuk; Laurence Klotz
Journal:  Nat Rev Urol       Date:  2011-04-26       Impact factor: 14.432

2.  Dialysis modality after renal transplant failure.

Authors:  Clare Castledine; Fergus J Caskey
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

3.  Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.

Authors:  Matthew R Cooperberg; Naren R Ramakrishna; Steven B Duff; Kathleen E Hughes; Sara Sadownik; Joseph A Smith; Ashutosh K Tewari
Journal:  BJU Int       Date:  2012-12-28       Impact factor: 5.588

4.  Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.

Authors:  Jenny L Donovan
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

5.  Development and impact of an intervention to boost recruitment in a multicenter pediatric randomized clinical trial.

Authors:  Sonika Bhatnagar; Alejandro Hoberman; Diana H Kearney; Nader Shaikh; Marva M Moxey-Mims; Russell W Chesney; Myra A Carpenter; Saul P Greenfield; Ron Keren; Tej K Mattoo; Ranjiv Mathews; Lisa Gravens-Mueller; Anastasia Ivanova
Journal:  Clin Pediatr (Phila)       Date:  2013-10-22       Impact factor: 1.168

6.  The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?

Authors:  Simon M Collin; Chris Metcalfe; Tom M Palmer; Helga Refsum; Sarah J Lewis; George Davey Smith; Angela Cox; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-28

7.  Increasing human papillomavirus vaccine initiation among publicly insured Florida adolescents.

Authors:  Stephanie A S Staras; Susan T Vadaparampil; Melvin D Livingston; Lindsay A Thompson; Ashley H Sanders; Elizabeth A Shenkman
Journal:  J Adolesc Health       Date:  2015-05       Impact factor: 5.012

8.  Patient advocacy and patient centredness in participant recruitment to randomized-controlled trials: implications for informed consent.

Authors:  Zelda Tomlin; Isabel deSalis; Merran Toerien; Jenny L Donovan
Journal:  Health Expect       Date:  2012-06-19       Impact factor: 3.377

9.  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Authors:  J L Donovan; F C Hamdy; J A Lane; D E Neal; M Mason; C Metcalfe; E Walsh; J M Blazeby; T J Peters; P Holding; S Bonnington; T Lennon; L Bradshaw; D Cooper; P Herbert; J Howson; A Jones; N Lyons; E Salter; P Thompson; S Tidball; J Blaikie; C Gray; P Bollina; J Catto; A Doble; A Doherty; D Gillatt; R Kockelbergh; H Kynaston; A Paul; P Powell; S Prescott; D J Rosario; E Rowe; M Davis; E L Turner; R M Martin
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

10.  The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer.

Authors:  D W Hamilton; I de Salis; J L Donovan; M Birchall
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-20       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.